No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. 2005

A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
Leukaemia Research Fund Cytogenetics Group, Cancer Sciences Division, University of Southampton, Southampton General Hospital, Southampton, UK. avm@soton.ac.uk

This study characterized the additional chromosomal abnormalities (ACA) associated with 11q23 rearrangements in 450 infants and children with acute lymphoblastic leukemia (ALL) and examined the impact of these ACA on survival. Overall, 213 (47%) cases had ACA but the incidence varied according to patient age and 11q23 subgroup. Infants and patients with t(4;11)(q21;q23) had the lowest incidence of ACA (50/182 (27%) and 57/216 (26%) respectively), whereas patients with del(11)(q23) had the highest incidence (66/93 (71%)). Del(11)(q23) abnormalities were heterogeneous and occasionally secondary to t(9;22)(q34;q11.2). Thus, patients with del(11)(q23) comprised a separate biological entity, which was clearly distinct from those with an 11q23 translocation. The most frequent specific ACA were trisomy X (n = 38), abnormal 12p (n = 32), abnormal 9p (n = 28) and del(6q) (n = 19). The presence of ACA did not change the 5 year event-free survival estimates among children (56% (95% Cl 46-65%) vs 62% (54-69%)) or infants (22% (15-29%) vs 18% (9-29%)), nor when the different 11q23 subgroups were analyzed separately. This study has conclusively demonstrated that there is no prognostic effect of secondary chromosomal changes in association with 11q23 abnormalities in childhood ALL. However, characterization of these ACA is important to determine their potential role in initiation of MLL driven leukemogenesis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
January 2014, Asian Pacific journal of cancer prevention : APJCP,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
October 2008, Leukemia research,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
May 1989, Blood,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
October 2017, Cancer genetics,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
November 1981, Cancer research,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
November 2009, Annals of hematology,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
May 1989, Blood,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
May 2004, Journal of pediatric hematology/oncology,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
January 2009, Vestnik Rossiiskoi akademii meditsinskikh nauk,
A V Moorman, and S C Raimondi, and C H Pui, and A Baruchel, and A Biondi, and A J Carroll, and E Forestier, and P S Gaynon, and J Harbott, and D O Harms, and N Heerema, and R Pieters, and M Schrappe, and L B Silverman, and E Vilmer, and C J Harrison, and
January 1986, Acta haematologica,
Copied contents to your clipboard!